Stephen K. Horrigan
Chief Tech/Sci/R&D Officer at Noble Life Sciences, Inc.
Stephen K. Horrigan active positions
| Companies | Position | Start | End |
|---|---|---|---|
Noble Life Sciences, Inc.
 Noble Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Noble Life Sciences, Inc. provides in vitro and in vivo preclinical drug development services. It specializes in personalized medicine and biomarker research and preclinical drug development. The company was founded by Kenneth C. Carter in 2010 and is headquartered in Sykesville, MD. | Chief Tech/Sci/R&D Officer | - | - |
Career history of Stephen K. Horrigan
Former positions of Stephen K. Horrigan
| Companies | Position | Start | End |
|---|---|---|---|
| Georgetown University | Corporate Officer/Principal | - | - |
Avalon Pharmaceuticals, Inc.
 Avalon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Avalon Pharmaceuticals, Inc. was a biopharmaceutical company focused on the discovery, development and commercialization of cancer therapeutics. The company was founded in November 1999 and headquartered in Germantown, MD. | Chief Tech/Sci/R&D Officer | 30/06/2000 | - |
Training of Stephen K. Horrigan
| Syracuse University | Doctorate Degree |
Statistics
International
| United States | 5 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Avalon Pharmaceuticals, Inc.
Avalon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Avalon Pharmaceuticals, Inc. was a biopharmaceutical company focused on the discovery, development and commercialization of cancer therapeutics. The company was founded in November 1999 and headquartered in Germantown, MD. | Health Technology |
Noble Life Sciences, Inc.
Noble Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Noble Life Sciences, Inc. provides in vitro and in vivo preclinical drug development services. It specializes in personalized medicine and biomarker research and preclinical drug development. The company was founded by Kenneth C. Carter in 2010 and is headquartered in Sykesville, MD. | Health Technology |
- Stock Market
- Insiders
- Stephen K. Horrigan
- Experience
